Avobis Bio Receives FDA Fast Track Designation for AVB-114 Implantable Cell Therapy for Crohn's Perianal Fistulas

– Only implantable cell therapy for Crohn's perianal fistulas with FDA IND clearance and Fast Track designation – NEWARK, Del., Feb. 27, 2025 /PRNewswire/ -- Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced today that the U.S. Food and Drug...